Text Size
2641 studies found for:    "Colorectal Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Matrilysin Expression in Different Stages of Colorectal Tumors
Conditions: Colorectal Cancer Stage 0;   Colorectal Cancer Stage I;   Colorectal Cancer Stage II;   Colorectal Cancer Stage III;   Colorectal Cancer Stage IV
Intervention: Procedure: colonic or colorectal resection
2 Recruiting Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer
Conditions: Colorectal Neoplasms;   Colorectal Cancer;   Colorectal Tumor;   COlorectal Carcinoma
Intervention: Drug: Iodine-124 labeled humanized A33 (antibody)
3 Completed Safety Study of 90Y-hMN14 to Treat Colorectal Cancer
Conditions: Colorectal Cancer;   Colon Cancer;   Rectal Cancer;   Colorectal Neoplasms;   Colorectal Carcinoma;   Colorectal Tumor
Intervention: Drug: hMN14 (labetuzumab)
4 Recruiting A Study of Famitinib in Patients With Advanced Colorectal Cancer
Conditions: Colorectal Cancer;   Colorectal Cancer Metastatic;   Colorectal Cancer Recurrent
Intervention: Drug: Famitinib
5 Completed Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
Conditions: Colorectal Neoplasms;   Digestive System Diseases;   Colonic Diseases;   Colorectal Cancer
Intervention:
6 Active, not recruiting Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy
Conditions: Colorectal Cancer;   Colorectal Neoplasm
Interventions: Procedure: Immunochemical fecal occult blood test;   Procedure: Colonoscopy
7 Recruiting Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)
Conditions: Colorectal Neoplasms;   Colorectal Cancer;   Colorectal Carcinoma;   Colorectal Tumors;   Neoplasms, Colorectal
Intervention: Biological: DC Vaccine
8 Recruiting ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer
Conditions: Colorectal Neoplasms;   Colorectal Carcinoma;   Colorectal Tumors
Interventions: Drug: ISIS 183750;   Drug: Irinotecan
9 Unknown † Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
Conditions: Colorectal Cancer;   Hereditary Nonpolyposis Colorectal Cancer;   Precancerous Condition
Interventions: Other: study of socioeconomic and demographic variables;   Procedure: evaluation of cancer risk factors;   Procedure: study of high risk factors
10 Completed Colorectal Cancer Screening Intervention Trial
Conditions: Colorectal Cancer;   Colorectal Cancer Screening
Interventions: Other: Control;   Other: Reduced out of pocket expense;   Behavioral: one on one education;   Behavioral: Group education
11 Recruiting Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer
Conditions: Colorectal Cancer;   Colorectal Carcinoma;   Colorectal Tumors;   Neoplasms, Colorectal
Interventions: Drug: Panitumumab;   Drug: Irinotecan;   Drug: Everolimus
12 Unknown † Implementation of a New Strategy to Identify HNPCC Patients
Conditions: Colorectal Neoplasms;   Hereditary Nonpolyposis Colorectal Cancer
Interventions: Behavioral: Education for professionals;   Behavioral: Distribution of educational materials;   Behavioral: Feedback for professionals;   Behavioral: Reminders for professionals
13 Completed
Has Results 		Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Responsive to Fluoropyrimidines;   Advanced Colorectal Cancer;   Neoplasms, Colorectal
Interventions: Drug: lapatinib;   Drug: oxaliplatin;   Drug: capecitabine
14 Recruiting Endoscopic Submucosal Dissection Versus Laparoscopic Resection for Early Colorectal Neoplasms
Condition: Colorectal Neoplasms
Interventions: Procedure: Endoscopic submucosal dissection;   Procedure: Laparoscopic resection
15 Completed A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer
Conditions: Advanced Colorectal Cancer;   Colorectal Cancer
Intervention: Drug: CP-4055
16 Active, not recruiting Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Colon Cancer;   Colorectal Cancer;   Rectal Cancer
Interventions: Drug: Placebo;   Drug: AMG 655
17 Recruiting The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer
Conditions: Colorectal Cancer;   Surgical Resection of the Colorectal Tumor
Intervention:
18 Active, not recruiting Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
Conditions: Metastatic Colorectal Cancer;   Colorectal Cancer
Interventions: Drug: MORAb-004;   Drug: Placebo
19 Active, not recruiting PEAK: A Phase 2 Study of Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer Subjects With Wild-Type KRAS Tumors
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: Bevacizumab;   Drug: mFOLFOX6
20 Completed New Individualized Therapy Trial for Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasm;   Colorectal Cancer
Interventions: Drug: Imatinib mesylate followed by a combination of imatinib mesylate & panitumumab;   Drug: Standard-of-care treatment with panitumumab
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years